Resolutions were fully adopted at the Valbiotis AGM

On April 17, 2026, in La Rochelle, Valbiotis held its Combined General Meeting under the chairmanship of Sébastien Peltier. All resolutions were adopted by a large majority of shareholders. This included the renewal and two new appointments to the Supervisory Board.

Among these appointments, Patricia Tranvouëz and Laurent Keiser, both experts in pharmaceutical marketing and distribution, are joining the Board. These additions aim to support Valbiotis' growth in France and internationally. Ms. Tranvouëz brings extensive experience in brand strategy, while Mr. Keiser brings a deep understanding of pharmacy distribution channels.

The documents relating to the General Meeting are available on the Valbiotis website. Shareholders also benefit from a discount on Valbiotis products.